In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Flavaxin Drug Master File in Korea (Flavaxin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Flavaxin. The MFDS reviews the Flavaxin KDMF as part of the drug registration process and uses the information provided in the Flavaxin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Flavaxin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Flavaxin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Flavaxin suppliers with KDMF on PharmaCompass.